Kyle Edgar
About Kyle Edgar
Kyle Edgar is a Sr. Principal Scientist at ORIC Pharmaceuticals, with a background in biochemistry and molecular cell biology. He has held various research positions at notable companies including Exelixis, Genentech, and Chiron Corporation.
Current Role at ORIC Pharmaceuticals
Kyle Edgar serves as a Senior Principal Scientist at ORIC Pharmaceuticals. He has held this position since 2019, contributing to the company's research and development efforts. His role involves leading scientific initiatives and collaborating with teams to advance the company's drug discovery programs.
Previous Experience at Genentech
Prior to his current role, Kyle Edgar worked at Genentech as a Principal Scientific Researcher from 2005 to 2019. During his 14 years at Genentech, he engaged in various research projects that contributed to the development of innovative therapies. His extensive experience in this role helped shape his expertise in the biopharmaceutical field.
Early Career at Exelixis
Kyle Edgar began his career at Exelixis, where he worked as a Research Technician from 1998 to 2000 and later as a Research Associate from 2000 to 2005. His five years at Exelixis provided him with foundational experience in scientific research and laboratory techniques, which he built upon in his subsequent roles.
Education in Biochemistry
Kyle Edgar earned his Bachelor of Science degree in Biochemistry and Molecular Cell Biology from the University of Arizona. He studied from 1994 to 1998, gaining a solid academic background that prepared him for a career in scientific research and development.
Short Tenure at Chiron Corporation
In 2005, Kyle Edgar briefly worked at Chiron Corporation as a Specialist for three months. This role contributed to his diverse experience in the biotechnology sector before he transitioned to a longer tenure at Genentech.